We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$119M
AUM Growth
+$3.11M
Cap. Flow
+$619K
Cap. Flow %
0.52%
Top 10 Hldgs %
22.99%
Holding
184
New
25
Increased
49
Reduced
67
Closed
21

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$881K
2
DRI icon
Darden Restaurants
DRI
+$766K
3
URI icon
United Rentals
URI
+$730K
4
IBP icon
Installed Building Products
IBP
+$692K
5
ACM icon
Aecom
ACM
+$691K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.48M
2
ADI icon
Analog Devices
ADI
+$1.13M
3
PRXL
Parexel International Corp
PRXL
+$1.1M
4
MSFT icon
Microsoft
MSFT
+$969K
5
JWN
Nordstrom
JWN
+$833K

Sector Composition

Rank Sector Weight
1 Industrials 18.45%
2 Healthcare 16.9%
3 Consumer Staples 13.84%
4 Financials 13.02%
5 Consumer Discretionary 11.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESRX
176
DELISTED
Express Scripts Holding Company
ESRX
– –
-3,450
Closed -$262K
PSG
177
DELISTED
Performance Sports Group Ltd.
PSG
– –
-23,309
Closed -$70K
4 5 6 7
8

Similar funds

GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return
FAFN
First Affirmative Financial Network Colorado Springs, Colorado $258M AUM
CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return

New England Research & Management's Q3 2016 Portfolio in Review

As of Q3 2016, New England Research & Management held 184 positions worth $119M, up 2.7% from $116M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

New England Research & Management's Q3 2016 filing shows 25 new, 49 increased, 67 reduced and 21 closed positions. Its largest new stake was Installed Building Products: 19,900 shares worth $714K. The largest sale was Merck, an estimated $1.48M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Staples.

  • New England Research & Management's largest Q3 2016 buy was Installed Building Products: 19,900 shares worth $714K.
  • New England Research & Management added most to Bristol-Myers Squibb in Q3 2016, an estimated $881K increase.
  • New England Research & Management's biggest Q3 2016 reduction was Merck, cutting an estimated $1.48M.
  • New England Research & Management fully exited Analog Devices in Q3 2016, selling an estimated $1.13M.
  • New England Research & Management's ten largest holdings make up 23% of its $119M portfolio in Q3 2016.
  • New England Research & Management opened 25 new positions and closed 21 in Q3 2016.
  • New England Research & Management's portfolio value rose 2.7% quarter-over-quarter to $119M.

Based on New England Research & Management's 13F filing for Q3 2016, filed 5 Oct 2016.